All News

Social interaction during chemotherapy treatments can positively influence a cancer patient’s health through improving patient outcomes and patient survival rates.

In a webinar hosted by Carevive, researcher Ethan Basch, MD, MSc, discussed the findings of his recent study linking electronic patient-reported outcomes (PROs) to better survival outcomes for patients with cancer.

The data confirm what Medicaid beneficiaries report and what a study by a Wharton School professor found: physicians' willingness to take on Medicaid patients is directly related to reimbursement rates.

The study found that no matter their eating pattern, participants tended to add weight gradually until age 60, then lose it gradually. But those who had most of their calories earlier in the day gained less and lost weight more rapidly after age 60.

Researchers at the University of Pennsylvania have recognized that narrow provider networks are quite likely to exclude National Cancer Institute—Designated Cancer Centers or National Comprehensive Cancer Network Cancer Centers, which could prevent patient access to high-quality cancer care.

In a recently released position statement, the American Society of Clinical Oncology (ASCO) has outlined a pathway that would address the rising costs of cancer drugs in the United States.

The FDA recently approved Vosevi-a fixed-dose combination tablet containing FDA-approved sofosbuvir and velpatasvir, and a new drug, voxilaprevi-to treat adults with the hepatitis C virus who do not have cirrhosis (liver disease).

The majority of patients with chronic obstructive pulmonary disease (COPD) do not receive positive airway pressure (PAP) therapy despite its effectiveness in reducing hospitalizations, according to research.

Researchers at the Beth Israel Deaconess Medical Center in Boston investigated the impact of patient engagement in evaluating their care visit notes and found patients and care partners who chose to provide feedback were enthusiastic about assisting with improving the accuracy of clinician notes.

The National Quality Forum (NQF) has issued a report detailing the results of its experiment with including social risk factors in its risk adjustment models for performance measures.

If there's good news, it's that the rate of increase in number of individuals with diabetes seems to be slowing. But the disease is hitting hardest on the populations with the fewest resources to manage it.

Another showdown is looming between a leading academic medical center and a payer it seemingly can’t live without, and once again it’s about Medicaid.

Report notes that 74% of drugs that are currently in development are potentially first-in-class medicines, and 822 drugs in development are for rare diseases.

According to findings from a 63-center international study, published in the New England Journal of Medicine, complete lymph node excision may not be essential for improved outcomes in melanoma.

The FDA has approved neratinib (Nerlynx) for the extended adjuvant treatment of some forms of breast cancer, but recommends precautions against the common side effect of diarrhea.

The report foresees the rules for durable medical equipment becoming increasingly inadequate to keep pace with technology advances, and wants a review of policies.

With plans to repeal and simultaneously replace the Affordable Care Act derailed now that 4 Republican senators have announced they would oppose the Better Care Reconciliation Act of 2017, Senate Majority Leader Mitch McConnell (R-Kentucky) is returning to an older plan: repeal and delay.

With 2 more Republicans announcing that they oppose the Senate healthcare bill, Senate Majority Leader Mitch McConnell (R-Kentucky) no longer has enough votes to pass the Better Care Reconciliation Act of 2017, which would repeal and replace parts of the Affordable Care Act.

The British study found that just an hour a week of added social interaction, and letting patients have a say in their care plan, reduced agitation and improved quality of life for Alzheimer's patients. This method also reduced costs, which has implications for Medicare as the Alzheimer's populaton is expected to grow in Medicare.

The proposal to mostly leave virtual providers out of the 2018 launch of the Medicare Diabetes Prevention Program makes no sense in light of the evidence that these programs work.

According to a recent study, adding a stimulator of interferon genes (STING) agonist to rituximab for lymphoma can help provoke an immune response to the monoclonal antibody in patients who had shown resistance.

Proposed change to the payment rate under the 340B program for certain Medicare Part B drugs would cut reimbursement rate in attempt to address rising drug costs.

Patients with long-term conditions are more inclined to choose services with person-centered care attributes, according to recent research.

New research finds that having a retail health clinic nearby can make patients less likely to visit the emergency department for minor or preventable conditions.

The FDA is considering adding the risk of ocular inflammatory conditions to labels for 3 immune checkpoint inhibitors due to sight-threatening complications.